Respiratory virus testing: how I read a positive or negative result

When I read a respiratory virus test result, I first ask what the assay detects. A molecular assay and an antigen assay answer related but different laboratory questions. The collection site, timing, controls, and reason for testing affect how much confidence I can place in either result.

Know the target before reading the line

A nucleic acid amplification test (NAAT), including PCR-based assays, looks for specified viral genetic material. An antigen test looks for specified viral proteins. The test instructions define which viruses, specimen types, and conditions the assay is designed for. I never treat a test for one target as a screen for every respiratory virus.

A detected target is evidence that the assay found that target in the submitted specimen. It does not, by itself, prove that viable virus is present or establish the precise stage of illness. A “not detected” result means the target was not found under that test’s conditions; it is not a guarantee that infection is absent.

Check the specimen and controls

I review whether the specimen type matches the assay instructions, when it was collected relative to symptoms or exposure, and whether transport and processing met the procedure. Poor collection can leave too little target in the sample. I then check the run’s controls and any internal control or invalid-result flag. If the quality checks fail, I do not convert an invalid run into a negative result.

Why a negative antigen result deserves care

Antigen assays can be faster, but their lower sensitivity than molecular assays means some infections can be missed. This matters especially when the suspected virus is circulating and the clinical question remains strong. The next step—repeat testing, a molecular test, or clinical follow-up—depends on the assay, setting, and current guidance; I do not invent a one-size-fits-all rule from a single line on a device.

My result-reading checklist

1. Which virus and target does this assay detect?
2. Is this specimen type and collection window appropriate?
3. Did the required controls pass?
4. Is the result detected, not detected, or invalid?
5. What does the result support, and what does it leave uncertain?

I keep those five questions visible in the report narrative. They help me communicate the limits of the test without overclaiming what a positive or negative result means.

Further reading

CDC guidance on rapid influenza diagnostic tests explains the limits of antigen testing and cautious interpretation of negative results. This article is educational; clinical decisions follow the applicable assay instructions and current local guidance.